Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Series C financing at Novagali Pharma

April 18, 2006

Preclinical and clinical studies examine ocular effects of bevacizumab

April 11, 2006

New phase II study evaluates OT-551 in geographic atrophy

April 7, 2006

QLT and Retinagenix sign agreement in retinal diseases

April 7, 2006

Initial preclinical data for ReN-003 retinal stem cell therapy program

April 6, 2006

New Astellas patent imparts novel treatment option for macular edema

April 5, 2006

CF-101 to begin trial in dry eye symptoms, subject of MOU for Japan

April 5, 2006

BioInvent and Immusol collaborate on antibody therapeutics for AMD

April 5, 2006

Santen and Oakwood sign agreement on microsphere-based product for DME

April 4, 2006

Positive opinion handed down in Europe for Ganfort

March 28, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...